In the subgroup of patients who were obese at the beginning of the trials, the weight changes were more substantial
Seventy-five percent of the cohort was white (n=76), 2% identified as other (n=2), 23% identified as black (n=24), and 1% (n=1) was Hispanic
GLP-1 medications, such as semaglutide (the active ingredient in Ozempic and Wegovy), have gained global attention for their ability to help people lose significant weight while improving insulin sensitivity and reducing appetite
That makes the work involved in putting these together especially worthwhile
Ozempic staat erom bekend een stuk patintvriendelijker te zijn voor diabetespatinten dan andere middelen tegen suikerziekte
In general, therapeutic candidates currently in the clinic are focused on modulating metabolic pathways, reducing inflammation and/or fibrosis